11 /100
LOW RISK
Score updated May 29, 2026

AMBA — Ambarella, Inc. Dilution Risk Tracker

Track AMBA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AMBA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for AMBA.
🔔 Track AMBA — Get forecast alerts →

💹 Market Data

Market Cap$4.03B
Shares Outstanding43.86M
Float41.68M
Cash$312.57M
Debt$13.44M
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 18.24M shares
#1 Blackrock Inc. 3.79M shares
#2 Vanguard Portfolio Management LLC 3.72M shares
#3 State Street Corporation 1.98M shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest2.63M
Days to Cover3.5
% of Float6.3%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Jan 31, 2013
xbrl XBRL WARRANT Jan 31, 2013
Form 4 INSIDER TRANSACTION Apr 21, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
Full SEC filing analysis available with free account →

📰 Recent News

Did Ambarella’s New Edge AI Analyst Briefings Just Reframe Its (AMBA) Go‑to‑Mark Simply Wall St. · May 22
Northland Securities Turns Incrementally Bullish on Ambarella (AMBA) Insider Monkey · Apr 12
Track AMBA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AMBA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: A AAON ABLZF ACIW ADM
🔬 More Research for AMBA
📊 AMBA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 AMBA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.